Premium
Impact of the CYP2C19*17 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Proton Pump Inhibitors
Author(s) -
MazerAmirshahi Maryann,
van den Anker John
Publication year - 2013
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.18
Subject(s) - cyp2c19 , pharmacokinetics , pharmacodynamics , proton pump inhibitor , pharmacology , medicine , polymorphism (computer science) , population , helicobacter pylori , genotype , biology , genetics , metabolism , gene , environmental health , cytochrome p450
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom